Presentation is loading. Please wait.

Presentation is loading. Please wait.

Copyright Rib-X, Inc. 2005 – All Rights Reserved Susan Froshauer, Ph.D. President and CEO.

Similar presentations


Presentation on theme: "Copyright Rib-X, Inc. 2005 – All Rights Reserved Susan Froshauer, Ph.D. President and CEO."— Presentation transcript:

1

2 Copyright Rib-X, Inc. 2005 – All Rights Reserved Susan Froshauer, Ph.D. President and CEO

3 Copyright Rib-X, Inc. 2005 – All Rights Reserved Our Mission To Rapidly Design and Develop the Next Generation of Antibiotics Active Against Drug Resistant Bacteria

4 Many Antibiotics Inhibit the Ribosome 50S30S Zithromax Biaxin Zyvox Ketek Cleocin Chloromycetin Synercid Inhibitors Aminoglycosides Tetracyclines mRNA Decoding Peptide bond formation

5 Copyright Rib-X, Inc. 2005 – All Rights Reserved Rib-X Business Plan Fully exploit Rib-X research and development capability to build a sustainable company Establish a strong pipeline of differentiable drugs Partnerships to leverage our assets and to expand outreach and global potential Revenue via such commercialization partnerships and ultimately a focused Rib-X sales force

6 Copyright Rib-X, Inc. 2005 – All Rights Reserved Waves of Programs Build Pipeline 2004200520062007 Clinical Trials Phase 2 Clinical Trials Phase 1 Late Preclinical Clinical Trials Phase 2 Clinical Trials Phase 1 Commercial Partnership IND 200420052006 Copyright Rib-X Inc. 2005 – All Rights Reserved NCE Development R  02 2007 New Programs Commercial Partnership Drug Candidates R  03 Late Preclinical R  01 NCE Development Late Preclinical Clinical Trials Phase 1 Clinical Trials Phase 3

7 Copyright Rib-X, Inc. 2005 – All Rights Reserved Business Highlights Research Initiated, June, ‘01 $ 9.5 MM, Series A, Dec., ‘01 $ 63.5 MM, Series B, May ’03 Multiple, Parallel & Distinct Drug Dev Programs Clinic with 1st Program during 2005 Commercial Partnerships in Phase I/II

8 Copyright Rib-X, Inc. 2005 – All Rights Reserved Rib-X Culture 50 Employees 42 Ph.D.s, 1 MBA, 3 Specialized Training Local Institutions- Yale, Large Pharma US Biotech Companies and other Academic Institutions International

9 Copyright Rib-X, Inc. 2005 – All Rights Reserved Rib-X Benefits from CT Rib-X Benefits from CT Nucleation and Cash Flow

10 Copyright Rib-X, Inc. 2005 – All Rights Reserved Scientific Founders Thomas A. Steitz, Ph.D. SAB Chair and Co-founder Yale University Peter B. Moore, Ph.D. Co-founder Yale University Harry F. Noller, Ph.D. Co-founder University of California, Santa Cruz John N. Abelson, Ph.D. Co-founder California Institute of Technology William L. Jorgensen, Ph.D. Co-founder Yale University

11 Copyright Rib-X, Inc. 2005 – All Rights Reserved Yale Technology Transfer Exclusive Licenses to: Ribosome Crystal Structure  Patent  Know-how Computational Chemistry Software & Code

12 Copyright Rib-X, Inc. 2005 – All Rights Reserved Private Equity Investors, Including CT Venture Capital ABS Ventures Axiom Venture Partners Cardinal Partners Connecticut Innovations EuclidSR Partners Oxford Bioscience Partners S.R. One, Limited Warburg Pincus (Series B Lead) Zero Stage Capital

13 Copyright Rib-X, Inc. 2005 – All Rights Reserved Connecticut Innovations Valuable to Rib-X Connecticut Innovations Private Equity Fund  Seed Investors($ 1.2 MM) Connecticut Innovation’s Lab Space  Science Park Incubator Space  Modest interest loan to build 29,000 square ft George Street Laboratory Facilities ($ 3.1 MM, 5yrs)

14 Copyright Rib-X, Inc. 2005 – All Rights Reserved Connecticut Benefits- Increase Rib-X Runway R & D Tax Credit Preferential Personal Property Tax New Haven Enterprise Zone

15 Copyright Rib-X, Inc. 2005 – All Rights Reserved Rib-X Outreach to Organizations Smoothes the Way Yale  SOM  Library  Fee for Service- Equipment, Keck Facility  Scientific Community  Educated Workforce CBIA  Bulk buying power (health insurance)  HR Resources/Information  Training and Key Certifications CURE  On-line info (permitting requirements)  Promotion of Biotech Cluster Build

16 Copyright Rib-X, Inc. 2005 – All Rights Reserved CT Might Do More…. Patient Money and Incentives

17 Copyright Rib-X, Inc. 2005 – All Rights Reserved Stimulating the Biotech Cluster $$ Seed FundingMezzanine Diversity of Business Plans- Synergies- Benefits Involve Local Pharma/Biotech- Define Needs Administrative Resources Connected, Committed, Savy Mentors Visionary Facilities- High Cost Equipment

18 Copyright Rib-X, Inc. 2005 – All Rights Reserved Susan Froshauer, Ph.D. President & CEO (203) 624-5606 froshauer@rib-x.com Thank you.


Download ppt "Copyright Rib-X, Inc. 2005 – All Rights Reserved Susan Froshauer, Ph.D. President and CEO."

Similar presentations


Ads by Google